The "Crohn's Disease Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Anti-inflammatory, Immune System Suppressors, Antibiotics, Surgical), By Region, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global crohn's disease therapeutics market size is expected to reach USD 4.7 billion by 2025, registering a 2.4% CAGR during the forecast period.
Increasing awareness of the disease, coupled with rising initiatives by regulatory bodies for development of novel treatment options, is estimated to provide the market with high growth potential.
For instance, the American Gastroenterological Association (AGA), in collaboration with Pfizer, supports research projects related to inflammatory bowel diseases and has offered three grants in their name. The Crohn's & Colitis Foundation, European Federation of Crohn's & Ulcerative Colitis Associations, and American Autoimmune Related Diseases Association are some of the organizations providing funds for research.
Furthermore, increase in prevalence of Crohn's disease has directed many companies to collaborate with various regulatory bodies and research institutes to introduce novel and effective treatment for the condition. In 2016, Pfizer's Centers for Therapeutic Innovation (CTI) collaborated with Johns Hopkins University to discover new medicines to treat Crohn's disease and ulcerative colitis.
Further key findings from the report suggest:
Key Topics Covered:
Chapter 1 Methodology & Scope
1.1. Research
Methodology
1.2. Research Scope & Assumptions
1.3. List of
Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Crohn's Disease Therapeutics Industry Outlook
3.1.
Market segmentation
3.2. Market size and growth prospects, 2014 -
2025
3.3. Value chain analysis
3.4. Regulatory Framework
3.5.
Market dynamics
3.5.1. Market driver analysis
3.5.2. Market
restraint analysis
3.6. Key opportunities prioritized
3.7.
Industry analysis - Porter's
3.8. PESTEL analysis, 2016
Chapter 4. Crohn's Disease Therapeutics: Therapy Type Outlook
4.1.
Crohn's disease therapeutics market share by therapy type, 2014 & 2025
(USD Billion)
4.2. Non-Surgical
4.3. Surgical
Chapter 5. Crohn's Disease Therapeutics Market: Regional Outlook
5.1.
Crohn's disease therapeutics market share by region, 2015 & 2025 (USD
Billion)
Chapter 6. Competitive Landscape
6.1. Strategy
Framework
6.2. Market Participation Categorization
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/chxzrp/global_crohns?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181113005906/en/
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs